直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

INCONTESTABLE® Blog

Extrinsic Evidence May Not Be Used To Distinguish the Commercial Impressions of Marks In An Ex Parte Likelihood-of-Confusion Analysis

December 4, 2017

Authored and Edited by Jonathan D. Uffelman; Naresh Kilaru; Julia Anne Matheson

In a non-precedential opinion, the Federal Circuit affirmed that in an ex parte proceeding, when analyzing the likelihood of confusion between a registered and an applied-for mark, evidence extrinsic to the application and cited registration may not be used to distinguish the commercial impressions made.

P.T. Arista Latindo applied to register the mark SENSI for adult and baby diapers, and diaper inserts.  The Examining Attorney refused registration, finding SENSI was likely to cause confusion with previously registered marks for SENSI-CARE that covered, among other things, medicated diaper rash ointments and lotions.  Arista appealed to the TTAB, arguing that the marks were dissimilar, the goods were unrelated, and there was no evidence of actual consumer confusion.  The Board disagreed. According to the Board, the goods, channels of trade, and classes of customers were all similar, as were the marks as a whole.  The Board also rejected Arista’s argument that evidence extrinsic to the registration and application could be used to differentiate the marks. 

On appeal to the Federal Circuit, Arista argued the Board should have considered Arista’s extrinsic evidence, which showed that its website used the tagline “Sensible way of living” near the mark SENSI at the top of its webpages.  According to Arista, given its website, customers would assume “SENSI” means “sensible,” whereas the cited registrations for SENSI-CARE, in context, refer to the term “sensitive.”  The Federal Circuit disagreed.

The Federal Circuit stated that under well-settled precedent, “[w]hen determining the meaning of two marks, it is the marks themselves, as set forth in the application and cited registration, not extrinsic evidence, which determines likelihood of confusion.”  Trade dress can be changed at any time and so cannot be used to prove differing commercial impressions.  The Court further rejected Arista’s argument that dictionary evidence showed that SENSI can be understood to mean “sensible.”  Artista’s cited dictionary did not define SENSI at all, but only noted that the word “sensible” was “nearby” alphabetically.  Nothing in the application indicated SENSI should be understood to mean “sensible,” and the slogan “Sensible way of living” did not appear in the application.  

Because the products were so closely related and nothing in the registrations or application provided any basis to find the terms would be understood differently, the Court affirmed the Board’s decision.

The case is In re: P.T. Artista Latindo, Case No. 2017-1292 (Fed. Cir. Nov. 13, 2017).

Tags

United States Court of Appeals for the Federal Circuit (CAFC), Trademark Trial and Appeal Board (TTAB), likelihood of confusion

Related Practices

Trademark and Brand Management

Contacts

Jonathan D. Uffelman
Domain Name Specialist / Attorney
Washington, DC
+1 202 408 4328
Email
Naresh Kilaru
Partner
Washington, DC
+1 202 408 4236
Email

Copyright © 2017 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Lecture

Munich Licensing Summer Course 2026

June 18-19, 2026

Munich

Charitable

Banding Together 2026

June 18, 2026

Washington, DC

Conference

2026 Copyright Society Annual Meeting

June 14-16, 2026

Louisville

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

Reception

12th Annual Georgia Asian Pacific American Bar Association Gala

May 21, 2026

Atlanta

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP